American Century Companies’s Agilon Health AGL Stock Holding History

American Century Companies’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,526	Closed	-$1.12M	–	2783
2025 Q2	$1.12M	Buy	19,526 +14,037	+256%	+$1.13M	﹤0.01%	2244
2025 Q1	$594K	Buy	+5,489	New	+$478K	﹤0.01%	2445
2024 Q2	–	Sell	-1,109	Closed	-$169K	–	2879
2024 Q1	$169K	Buy	1,109 +55	+5%	+$9.15K	﹤0.01%	2787
2023 Q4	$331K	Buy	1,054 +211	+25%	+$76.4K	﹤0.01%	2524
2023 Q3	$374K	Buy	843 +25	+3%	+$11.3K	﹤0.01%	2374
2023 Q2	$354K	Buy	818 +141	+21%	+$79.2K	﹤0.01%	2341
2023 Q1	$395K	Buy	677 +45	+7%	+$25.2K	﹤0.01%	2203
2022 Q4	$255K	Buy	632 +187	+42%	+$87.7K	﹤0.01%	2267
2022 Q3	$261K	Buy	+445	New	+$266K	﹤0.01%	2158

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies's AGL Position: Q3 2025 in Review

American Century Companies sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 19,526 shares — an estimated $1.12M sold.

American Century Companies first reported a position in AGL in Q3 2022 and held it in 9 quarters. The position peaked at $1.12M in Q2 2025. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

American Century Companies reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
American Century Companies sold 19,526 Agilon Health shares in Q3 2025, an estimated $1.12M.
American Century Companies first reported a position in Agilon Health in Q3 2022 and held it in 9 quarters.
American Century Companies's Agilon Health position peaked at $1.12M in Q2 2025.
190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.